Presentation Information
[P2-126]Modulating the immune cell fate with in vivo reprogramming technologies
*Yasuhiro Yamada1 (1. Graduate School of Medicine, The University of Tokyo (Japan))
Login required to view
Comment
To browse or post comments, you must log in.Log in